Interagency Committee on Smoking and Health: Notice of Charter Renewal, 22338 [2017-09708]
Download as PDF
22338
Federal Register / Vol. 82, No. 92 / Monday, May 15, 2017 / Notices
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters for Discussion: The agenda
will include discussions on:
Meningococcal vaccine; influenza;
hepatitis vaccines; herpes zoster
vaccine; varicella; yellow fever vaccine;
mumps disease and vaccine; Dengue
virus vaccines; Human Papillomavirus
(HPV); Anthrax vaccine workgroup;
Vaccine Adverse Event Reporting
System (VAERS) and vaccine supply. A
recommendation vote is scheduled for
hepatitis vaccines and influenza. A
Vaccines for Children (VFC) vote is
scheduled for hepatitis vaccines.
Agenda items are subject to change as
priorities dictate.
ACIP Charter: https://www.cdc.gov/
vaccines/acip/committee/charter.html.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–09707 Filed 5–12–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jstallworth on DSK7TPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Interagency Committee on Smoking
and Health: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Interagency Committee on Smoking and
Health, Department of Health and
VerDate Sep<11>2014
13:51 May 12, 2017
Jkt 241001
Human Services, has been renewed for
a 2-year period through March 20, 2019.
For information, contact Simon
McNabb, Designated Federal Officer,
Interagency Committee on Smoking and
Health, Centers for Disease Control and
Prevention, Department of Health and
Human Services, Patriot’s Plaza, 395 E
Street SW., M/S P06, Washington, DC
20201, telephone 202/245–0550 or fax
202/245–0599, Email: BOL1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–09709 Filed 5–12–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–D–2834]
Three-Month Extension of Certain
Tobacco Product Compliance
Deadlines Related to the Final
Deeming Rule; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
[FR Doc. 2017–09708 Filed 5–12–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns the Centers for Disease Control
and Prevention (CDC) initial review of
applications in response to Funding
Opportunity Announcement (FOA)
TS17–001, Identify and Characterize
Potential Environmental Risk Factors for
Amyotrophic Lateral Sclerosis (ALS),
TS17–001.
Summary: This publication corrects a
notice that was published in the Federal
Register on May 4, 2017, Volume 82,
No. 85, page 20895. The meeting time
and date should read as follows:
Time and Date: 8:00 a.m.–6:00 p.m.,
EST, June 14, 2017 (Closed).
Contact Person for More Information:
´
Oscar Tarrago, M.D., M.P.H., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
3492.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00034
Fmt 4703
The Food and Drug
Administration (FDA) is announcing the
availability of a guidance for industry
entitled ‘‘Three-Month Extension of
Certain Tobacco Product Compliance
Deadlines Related to the Final Deeming
Rule.’’ This guidance is intended to
assist persons who manufacture,
package, sell, offer to sell, distribute, or
import for sale and distribution within
the United States newly regulated
tobacco products, roll-your-own (RYO)
tobacco, and cigarette tobacco in
complying with the Federal Food, Drug,
and Cosmetic Act (the FD&C Act), as
amended by the Family Smoking
Prevention and Tobacco Control Act
(Tobacco Control Act), and FDA
regulations.
SUMMARY:
BILLING CODE 4163–18–P
Sfmt 4703
Submit either electronic or
written comments on Agency guidances
at any time.
ADDRESSES: You may submit comments
as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
E:\FR\FM\15MYN1.SGM
15MYN1
Agencies
[Federal Register Volume 82, Number 92 (Monday, May 15, 2017)]
[Notices]
[Page 22338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Interagency Committee on Smoking and Health: Notice of Charter
Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Interagency Committee on Smoking
and Health, Department of Health and Human Services, has been renewed
for a 2-year period through March 20, 2019.
For information, contact Simon McNabb, Designated Federal Officer,
Interagency Committee on Smoking and Health, Centers for Disease
Control and Prevention, Department of Health and Human Services,
Patriot's Plaza, 395 E Street SW., M/S P06, Washington, DC 20201,
telephone 202/245-0550 or fax 202/245-0599, Email: BOL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-09708 Filed 5-12-17; 8:45 am]
BILLING CODE 4163-18-P